<DOC>
	<DOCNO>NCT02440841</DOCNO>
	<brief_summary>The purpose study investigate potential co-administration strong inhibitor inducer CYP3A4 alter pharmacokinetics fedovapagon .</brief_summary>
	<brief_title>Study Healthy Male Subjects Evaluate Effect Itraconazole Rifampicin PK Fedovapagon</brief_title>
	<detailed_description>Fedovapagon vasopressin V2 receptor agonist development treatment nocturia . Agonism V2 receptor , locate collect duct kidney , lead translocation aquaporin channel increase absorption water anti-diuresis . A number drug commonly co-prescribed population may present treatment nocturia inhibitor CYP3A4 , include diltiazem , verapamil , erythromycin clarithromycin may therefore impact plasma level fedovapagon co administer . Conversely , concomitant intake drug potent CYP3A4 inducer may lead low anticipated plasma concentration fedovapagon thus reduce efficacy fedovapagon . It therefore important ass effect CYP3A4 induction pharmacokinetic ( PK ) parameter fedovapagon . The study design use itraconazole potent inhibitor CYP3A4 , separate cohort subject , rifampicin potent CYP3A4 inducer dos intend maximize potential demonstrate interaction .</detailed_description>
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy male age 18 45 Have body mass index 18 29.9 kg/m2 ( weight : ≥50 kg ≤100 kg ) No clinically significant medical history Ability comply requirement study Provide write informed consent Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) equal upper level normal ( ULN ) . Otherwise liver enzyme show clinical significant abnormality . Total bilirubin exceed 1.5 x ULN . Liver enzymes retested randomization require . Be judge Investigator good health base medical history ( particular , congestive heart failure , ischemic heart disease , valvular heart disease , significant pulmonary disease , renal failure , edematous disorder , liver disease , gastric disorder , porphyria , diabetes mellitus hereditary disorder carbohydrate metabolism ) , physical examination , vital sign measurement laboratory safety test Agree refrain consumption grapefruit grapefruit juice , apple orange juice , vegetables mustard green family ( e.g. , kale , broccoli , watercress , collard green , kohlrabi , brussels sprout , mustard ) charbroiled meat contain product begin 1 week prior administration initial administration trial drug , throughout trial Use prescribe medication St John 's Wort within 14 day ( 5 halflives longer ) overthecounter medication ( except paracetamol ) within 1 week dosing . Specific medication take within 2 week ( ) administration itraconazole describe Summary Product Characteristic Sempera®</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>VA106483</keyword>
	<keyword>fedovapagon</keyword>
	<keyword>drug-drug interaction</keyword>
	<keyword>DDI</keyword>
	<keyword>male</keyword>
	<keyword>rifampicin</keyword>
	<keyword>rifampin</keyword>
	<keyword>itraconazole</keyword>
	<keyword>CYP3A4</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>PK</keyword>
</DOC>